Hi,
I think the point SI made in one of the CC was Mesoblast have run two heart trials . CHF and a soon to be completed LVAD trial which I thought had 150
patients and the cohort very similar to CHF.
I also think it is fair to say Perin and the Texas Heart Institute are highly regarded.
In with a shot .
Aloha.
Ann: Biotech Showcase 2022 Presentation, page-15
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.030(2.63%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.11 | $5.555M | 4.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 118037 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 24029 | 13 |
View Market Depth
| Last trade - 14.19pm 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |